课题基金 / 基金详情

THE IMMUNOLOGY OF INCREASED AGGRESSIVENESS OF SJL TUMORS

THE IMMUNOLOGY OF INCREASED AGGRESSIVENESS OF SJL TUMORS
SJL 肿瘤侵袭性增强的免疫学
批准号:
3176843
负责人:
STEPHEN P LERMAN
金额:
$11.29万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-12-01 至 1987-11-30

项目摘要

项目成果

STEPHEN P LERMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
SJL strain mice spontaneously develop lymphomas which, upon transplantation in syngeneic mice, can grow either as indolent or aggressive tumors. Whereas indolent tumors are at constant risk of conversion to the aggressive type, aggressive tumors maintain their aggressiveness. The increase in aggressiveness of SJL lymphomas correlates with absence of H-2Ds, class I major histocompatibility complex (MHC) antigen from the tumor cell surface. It is, herein, proposed to test the hypothesis that the increased aggressiveness of H-2Ds negative (D-) SJL lymphomas may, in part, be attributed to: 1) deficient killing of D-tumor cells by cytotoxic T lymphocytes (CTL) as a consequence of preferential recognition of tumor antigen by CTL in association with H-2Ds; 2) deficient recognition and/or killing of D-tumor cells by natural killer cells, or; 3) a greater sensitivity of D-tumor cells to the stimulatory influence of lymphokines synthesized as a consequence of the T cell proliferation which accompanies the growth of most SJL lymphomas or a greater propensity of D-lymphomas to induce synthesis of such lymphokines. Since a similar increase in aggressiveness is seen during the progression of some human lymphomas, it is hoped that the results of this study will spur investigation of loss of class I MHC antigen as a potential prognostic indicator in humans. (MI)
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE--FLOW CYTOMETRY FACILITY
  • 批准号:
    6101936
  • 项目类别:
  • 资助金额:
    $8.63万
  • 财政年份:
    1999
  • 负责人:
    STEPHEN P LERMAN
  • 依托单位:
CORE--FLOW CYTOMETRY FACILITY
  • 批准号:
    6269030
  • 项目类别:
  • 资助金额:
    $6.23万
  • 财政年份:
    1998
  • 负责人:
    STEPHEN P LERMAN
  • 依托单位:
CORE--FLOW CYTOMETRY FACILITY
  • 批准号:
    6236471
  • 项目类别:
  • 资助金额:
    $10.7万
  • 财政年份:
    1997
  • 负责人:
    STEPHEN P LERMAN
  • 依托单位:
CHEMO/IMMUNOTHERAPY OF A T CELL DEPENDENT B CELL TUMOR
  • 批准号:
    3197391
  • 项目类别:
  • 资助金额:
    $14.21万
  • 财政年份:
    1990
  • 负责人:
    STEPHEN P LERMAN
  • 依托单位:
海外基金